Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Oxaliplatin Resistance in Colorectal Cancer Enhances TRAIL Sensitivity Via Death Receptor 4 Upregulation and Lipid Raft Localization

Joshua D. Greenlee, View ORCID ProfileMaria Lopez Cavestany, Nerymar Ortiz-Otero, Kevin Liu, Tejas Subramanian, View ORCID ProfileBurt Cagir, View ORCID ProfileMichael R. King
doi: https://doi.org/10.1101/2021.03.05.434100
Joshua D. Greenlee
1Vanderbilt University, Department of Biomedical Engineering, PMB 351631 2301 Vanderbilt Place, Nashville, TN 37235-1631
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Lopez Cavestany
1Vanderbilt University, Department of Biomedical Engineering, PMB 351631 2301 Vanderbilt Place, Nashville, TN 37235-1631
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Lopez Cavestany
Nerymar Ortiz-Otero
1Vanderbilt University, Department of Biomedical Engineering, PMB 351631 2301 Vanderbilt Place, Nashville, TN 37235-1631
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Liu
1Vanderbilt University, Department of Biomedical Engineering, PMB 351631 2301 Vanderbilt Place, Nashville, TN 37235-1631
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tejas Subramanian
1Vanderbilt University, Department of Biomedical Engineering, PMB 351631 2301 Vanderbilt Place, Nashville, TN 37235-1631
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Burt Cagir
2Donald Guthrie Foundation (DGF) for Research and Education, Sayre, PA 18840
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Burt Cagir
Michael R. King
1Vanderbilt University, Department of Biomedical Engineering, PMB 351631 2301 Vanderbilt Place, Nashville, TN 37235-1631
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael R. King
  • For correspondence: mike.king@vanderbilt.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Article usage

Article usage: March 2021 to January 2023

AbstractFullPdf
Mar 20211322030
Apr 202137514
May 202132714
Jun 202121159
Jul 2021421012
Aug 202134870165
Sep 2021682824
Oct 2021271138
Nov 202116722
Dec 20212218
Jan 202229429
Feb 202215513
Mar 202221222
Apr 202236121
May 202226223
Jun 202215282
Jul 2022161563
Aug 202210818
Sep 202216618
Oct 2022151122
Nov 202220621
Dec 202218615
Jan 2023131225
Back to top
PreviousNext
Posted March 05, 2021.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Oxaliplatin Resistance in Colorectal Cancer Enhances TRAIL Sensitivity Via Death Receptor 4 Upregulation and Lipid Raft Localization
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Oxaliplatin Resistance in Colorectal Cancer Enhances TRAIL Sensitivity Via Death Receptor 4 Upregulation and Lipid Raft Localization
Joshua D. Greenlee, Maria Lopez Cavestany, Nerymar Ortiz-Otero, Kevin Liu, Tejas Subramanian, Burt Cagir, Michael R. King
bioRxiv 2021.03.05.434100; doi: https://doi.org/10.1101/2021.03.05.434100
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Oxaliplatin Resistance in Colorectal Cancer Enhances TRAIL Sensitivity Via Death Receptor 4 Upregulation and Lipid Raft Localization
Joshua D. Greenlee, Maria Lopez Cavestany, Nerymar Ortiz-Otero, Kevin Liu, Tejas Subramanian, Burt Cagir, Michael R. King
bioRxiv 2021.03.05.434100; doi: https://doi.org/10.1101/2021.03.05.434100

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cancer Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4095)
  • Biochemistry (8788)
  • Bioengineering (6493)
  • Bioinformatics (23395)
  • Biophysics (11766)
  • Cancer Biology (9171)
  • Cell Biology (13292)
  • Clinical Trials (138)
  • Developmental Biology (7423)
  • Ecology (11389)
  • Epidemiology (2066)
  • Evolutionary Biology (15121)
  • Genetics (10415)
  • Genomics (14026)
  • Immunology (9152)
  • Microbiology (22111)
  • Molecular Biology (8793)
  • Neuroscience (47460)
  • Paleontology (350)
  • Pathology (1423)
  • Pharmacology and Toxicology (2486)
  • Physiology (3712)
  • Plant Biology (8069)
  • Scientific Communication and Education (1433)
  • Synthetic Biology (2216)
  • Systems Biology (6022)
  • Zoology (1251)